#antibody — Saturday, June 13, 2026 (1 items)
| 0 | 💬 0 |
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.
(nejm.org)
|
New England Journal of Medicine 2026-06-13 | #antibody #clinical trial #immunotherapy #myeloma #bispecific |